A human monoclonal antibody, produced following in vitro immunization, recognizing an epitope shared by HLA‐A2 subtypes and HLA‐A28

Authors:

Abstract
In vitro immunization and subsequent immortalization of peripheral blood cells of a multiparous woman has resulted in the production of a stable human mouse heterohybridoma, 5C2A2, secreting an HLA‐A2/A28‐specific human monoclonal antibody. Although possibly exposed to HLA‐A2 by transfusions, the cell donor showed no HLA‐A2‐specific serum antibodies. The present protocol for in vitro immunization includes the elimination of suppressor cells from the responder cell population, the presence of irradiated allogeneic lymphocytes as a source of antigen, as well as stimuli – recombinant interleukin‐2 and a B‐cell specific nucleoside analogue – causing the proliferation of B lymphocytes, prior to immortalization. The ability of the antibody 5C2A2 to detect all known HLA‐A2 subtypes, except A2.3, and A28, allows identification of the serological epitope on the HLA‐A2 molecule. Application of this in vitro immunization method allows the production of a set of HLA monoclonal antibody‐secreting human hybridomas, independent of the existence of serum HLA antibodies in the lymphocyte donors.

This publication has 29 references indexed in Scilit: